Mather Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4
| Closed | -$421 | – | 1238 |
|
|
2025
Q1 | $421 | Hold |
4
| – | – | ﹤0.01% | 1699 |
|
|
2024
Q4 | $429 | Hold |
4
| – | – | ﹤0.01% | 1671 |
|
|
2024
Q3 | $400 | Sell |
4
-24
| -86% | -$2.4K | ﹤0.01% | 1630 |
|
|
2024
Q2 | $2.05K | Buy |
28
+24
| +600% | +$1.76K | ﹤0.01% | 1882 |
|
|
2024
Q1 | $286 | Buy |
+4
| New | +$286 | ﹤0.01% | 1708 |
|